Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting

As of November 10, 2022, 26 patients with HER2-positive unresectable or metastatic solid tumors (other than breast cancer and gastric/gastroesophageal junction cancer) were enrolled, 92.3% of whom had received ≥2L prior systemic therapy. The objective response rate (ORR) was 53.8% with 6.8 months median duration of response (mDOR), 5.6 months median progression survival (mPFS) and […]

Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting

SUZHOU, China, June 6, 2023 /PRNewswire/ — Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of Cohort C from a phase I/IIa, multi-center study of Osemitamab (TST001) in combination with Capecitabine and Oxaliplatin (CAPOX) as a […]

RAYE Announces Debut Australian Tour

British singer RAYE will be heading to Australia for the first time in early 2024. The Londoner will play just two shows in the country – in Melbourne at the Forum Theatre on Thursday, 1st February and at Sydney’s Enmore Theatre a week later on Wednesday, 7th February. The shows form part of RAYE’s wider […]


PERTH, Australia, June 6, 2023 /PRNewswire/ — Vection Technologies Ltd (ASX:VR1, OTC:VCTNY) announces today the availability of its early release of ChatGPT-powered mixed reality solution, 3DFrame, on Apple’s macOS. 3DFrame is the solution developed by Vection Technologies that enables businesses to enhance their immersive product presentations and training experiences in 3D and virtual reality (VR). This […]

Back To Top